Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2

Sun,Zengxian; Liu,Yun; Hu,Rong; Wang,Tianyan; Li,Yanli; Liu,Naifeng

doi:10.3892/ijmm.2022.5104

Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2

Authors:
- Zengxian Sun
- Yun Liu
- Rong Hu
- Tianyan Wang
- Yanli Li
- Naifeng Liu
View Affiliations

Affiliations: School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, P.R. China, Department of Pharmacy, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222061, P.R. China, Department of Respiratory and Critical Care Medicine, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222061, P.R. China
Published online on: February 10, 2022 https://doi.org/10.3892/ijmm.2022.5104
Article Number: 49
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pulmonary artery hypertension (PAH) is a complex and progressive disease characterized by pulmonary vascular remodeling. Our previous study confirmed that NONRATT015587.2 could promote the proliferation of PASMCs and pulmonary vascular remodeling. However, the exact mechanism by which NONRATT015587.2 promotes PASMC proliferation is unclear. Bioinformatics analysis revealed that p21 is located at the downstream target of NONRATT015587.2. NONRATT015587.2 expression and localization were analyzed by PCR and fluorescence in situ hybridization. Proliferation was detected by Cell Counting Kit‑8, flow cytometry and western blotting. In the current study, a monocrotaline (MCT)‑induced PAH rat model and cultured pulmonary artery smooth muscle cells (PASMCs) were used in vitro to elucidate the exact mechanism of NONRATT015587.2 in pulmonary vascular remodeling, alongside the effect following metformin (MET) treatment on vascular remodeling and smooth muscle cell proliferation. The results demonstrated that NONRATT015587.2 expression was upregulated in the MCT group and reduced in the MET + MCT group. In addition, NONRATT015587.2 could promote the proliferation of PASMCs. The expression levels of p21 were reduced in the MCT group, but increased in the MCT + MET group. Additionally, the expression of NONRATT015587.2 was upregulated in platelet‑derived growth factor‑BB (PDGF‑BB)‑induced PASMCs, whereas that of p21 was downregulated. Following MET treatment, the expression of NONRATT015587.2 was downregulated and that of p21 was upregulated, which inhibited the proliferation of PASMCs. After overexpression of NONRATT015587.2 in vitro, the proliferation effect of PASMCs was consistent with exogenous PDGF‑BB treatment, and MET reversed this effect. NONRATT015587.2 silencing inhibited the proliferation of PASMCs. In addition, p21 silencing reversed the inhibitory effect of NONRATT015587.2 silencing on the proliferation of PASMCs. However, the proliferation of PASMCs was inhibited following MET treatment when NONRATT015587.2 and p21 were silenced at the same time. Thus, NONRATT015587.2 promoted the proliferation of PASMCs by targeting p21, and MET inhibited the proliferation of PASMCs by upregulating p21 mediated via NONRATT015587.2.

View Figures

View References

1	Wang D, Uhrin P, Mocan A, Waltenberger B, Breuss JM, Tewari D, Mihaly-Bison J, Huminiecki Ł, Starzyński RR, Tzvetkov NT, et al: Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: Molecular targets and pathways. Biotechnol Adv. 36:1586–1607. 2018. View Article : Google Scholar : PubMed/NCBI
2	Shimoda LA and Laurie SS: Vascular remodeling in pulmonary hypertension. J Mol Med (Berl). 91:297–309. 2013. View Article : Google Scholar
3	Liu Y, Sun Z, Zhu J, Xiao B, Dong J and Li X: LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. J Cell Physiol. 233:4801–4814. 2018. View Article : Google Scholar
4	Sun Z, Nie X, Sun S, Dong S, Yuan C, Li Y, Xiao B, Jie D and Liu Y: Long non-coding RNA MEG3 downregulation triggers human pulmonary artery smooth muscle cell proliferation and migration via the p53 signaling pathway. Cell Physiol Biochem. 42:2569–2581. 2017. View Article : Google Scholar : PubMed/NCBI
5	Thenappan T, Ormiston ML, Ryan JJ and Archer SL: Pulmonary arterial hypertension: Pathogenesis and clinical management. BMJ. 360:j54922018. View Article : Google Scholar : PubMed/NCBI
6	Johnson J, Lakshmanan G, M B, R M V, Kalimuthu K and Sekar D: Computational identification of MiRNA-7110 from pulmonary arterial hypertension (PAH) ESTs: A new microRNA that links diabetes and PAH. Hypertens Res. 43:360–362. 2020. View Article : Google Scholar
7	Whitaker ME, Nair V, Sinari S, Dherange PA, Natarajan B, Trutter L, Brittain EL, Hemnes AR, Austin ED, Patel K, et al: Diabetes mellitus associates with increased right ventricular afterload and remodeling in pulmonary arterial hypertension. Am J Med. 131:702.e7–702.e13. 2018. View Article : Google Scholar
8	Hemnes AR, Luther JM, Rhodes CJ, Burgess JP, Carlson J, Fan R, Fessel JP, Fortune N, Gerszten RE, Halliday SJ, et al: Human PAH is characterized by a pattern of lipid-related insulin resistance. JCI Insight. 4:e1236112019. View Article : Google Scholar :
9	Zhou T, Xu X, Du M, Zhao T and Wang J: A preclinical overview of metformin for the treatment of type 2 diabetes. Biomed Pharmacother. 106:1227–1235. 2018. View Article : Google Scholar
10	Li M, Li X, Zhang H and Lu Y: Molecular mechanisms of metformin for diabetes and cancer treatment. Front Physiol. 9:10392018. View Article : Google Scholar : PubMed/NCBI
11	Zi F, Zi H, Li Y, He J, Shi Q and Cai Z: Metformin and cancer: An existing drug for cancer prevention and therapy. Oncol Lett. 15:683–690. 2018.PubMed/NCBI
12	Ikhlas S and Ahmad M: Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways. Life Sci. 185:53–62. 2017. View Article : Google Scholar
13	Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, Rio M, Sagan C, Savineau JP, Loirand G and Pacaud P: Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol. 158:1285–1294. 2009. View Article : Google Scholar : PubMed/NCBI
14	Li S, Han D, Zhang Y, Xie X, Ke R, Zhu Y, Liu L, Song Y, Yang L and Li M: Activation of AMPK prevents monocrotaline-induced extracellular matrix remodeling of pulmonary artery. Med Sci Monit Basic Res. 22:27–33. 2016. View Article : Google Scholar : PubMed/NCBI
15	Zhai C, Shi W, Feng W, Zhu Y, Wang J, Li S, Yan X, Wang Q, Zhang Q, Chai L, et al: Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. Life Sci. 208:87–95. 2018. View Article : Google Scholar
16	Chaumeil J, Le Baccon P, Wutz A and Heard E: A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev. 20:2223–2237. 2006. View Article : Google Scholar : PubMed/NCBI
17	Gutschner T and Diederichs S: The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol. 9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
18	Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 34:5003–5011. 2015. View Article : Google Scholar :
19	Greco S, Gorospe M and Martelli F: Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol. 83:142–155. 2015. View Article : Google Scholar : PubMed/NCBI
20	Vencken SF, Greene CM and McKiernan PJ: Non-coding RNA as lung disease biomarkers. Thorax. 70:501–503. 2015. View Article : Google Scholar
21	Hou S, Chen D, Liu J, Chen S, Zhang X, Zhang Y, Li M, Pan W, Zhou D, Guan L and Ge J: Profiling and molecular mechanism analysis of long non-coding RNAs and mRNAs in pulmonary arterial hypertension rat models. Front Pharmacol. 12:7098162021. View Article : Google Scholar : PubMed/NCBI
22	Sun Z, Liu Y, Yu F, Xu Y, Yanli L and Liu N: Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline. Biomed Pharmacother. 115:1089332019. View Article : Google Scholar : PubMed/NCBI
23	Brock M, Schuoler C, Leuenberger C, Bühlmann C, Haider TJ, Vogel J, Ulrich S, Gassmann M, Kohler M and Huber LC: Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation. Exp Biol Med (Maywood). 242:487–496. 2017. View Article : Google Scholar
24	Zhang H, Liu Y, Yan L, Wang S, Zhang M, Ma C, Zheng X, Chen H and Zhu D: Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation. Cardiovasc Res. 115:647–657. 2019. View Article : Google Scholar
25	Su H, Xu X, Yan C, Shi Y, Hu Y, Dong L, Ying S, Ying K and Zhang R: LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res. 19:2542018. View Article : Google Scholar
26	Zhu TT, Sun RL, Yin YL, Quan JP, Song P, Xu J, Zhang MX and Li P: Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells. Pflugers Arch. 471:347–355. 2019. View Article : Google Scholar
27	Zhang Y, Wang Y, Wang X, Zhang Y, Eisner GM, Asico LD, Jose PA and Zeng C: Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens. 29:1560–1568. 2011. View Article : Google Scholar : PubMed/NCBI
28	Bi M, Yu H, Huang B and Tang C: Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in gastric cancer cells through regulating CDKN1A. Gene. 626:337–343. 2017. View Article : Google Scholar : PubMed/NCBI
29	Takahashi A, Kimura F, Yamanaka A, Takebayashi A, Kita N, Takahashi K and Murakami T: Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis. Cancer Cell Int. 14:532014. View Article : Google Scholar : PubMed/NCBI
30	Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, et al: In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol. 227:275–285. 2012. View Article : Google Scholar : PubMed/NCBI
31	Dean A, Nilsen M, Loughlin L, Salt IP and MacLean MR: Metformin reverses development of pulmonary hypertension via aromatase inhibition. Hypertension. 68:446–454. 2016. View Article : Google Scholar : PubMed/NCBI
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
33	Xu X, Gu J, Ding X, Ge G, Zang X, Ji R, Shao M, Mao Z, Zhang Y, Zhang J, et al: LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression. Cell Death Dis. 10:7522019. View Article : Google Scholar : PubMed/NCBI
34	Song Y, Wu Y, Su X, Zhu Y, Liu L, Pan Y, Zhu B, Yang L, Gao L and Li M: Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms. Pharmacol Res. 107:117–124. 2016. View Article : Google Scholar : PubMed/NCBI
35	Elgendy M, Cirò M, Hosseini A, Weiszmann J, Mazzarella L, Ferrari E, Cazzoli R, Curigliano G, DeCensi A, Bonanni B, et al: Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the 2A-GSK3β-MCL-1 axis. Cancer Cell. 35:798–815.e5. 2019. View Article : Google Scholar
36	Li B, Zhou P, Xu K, Chen T, Jiao J, Wei H, Yang X, Xu W, Wan W and Xiao J: Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma. Int J Biol Sci. 16:74–84. 2020. View Article : Google Scholar : PubMed/NCBI
37	Xia C, Liu C, He Z, Cai Y and Chen J: Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression. J Exp Clin Cancer Res. 39:1272020. View Article : Google Scholar : PubMed/NCBI
38	Zahra MH, Afify SM, Hassan G, Nawara HM, Kumon K, Seno A and Seno M: Metformin suppresses self-renewal and stemness of cancer stem cell models derived from pluripotent stem cells. Cell Biochem Funct. 39:896–907. 2021. View Article : Google Scholar
39	Liu Y, Xu Y, Zhu J, Li H, Zhang J, Yang G and Sun Z: Metformin prevents progression of experimental pulmonary hypertension via inhibition of autophagy and activation of adenosine monophosphate-activated protein kinase. J Vasc Res. 56:117–128. 2019. View Article : Google Scholar : PubMed/NCBI
40	Zhuang W, Lian G, Huang B, Du A, Gong J, Xiao G, Xu C, Wang H and Xie L: CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension. Mol Cell Biochem. 455:169–183. 2019. View Article : Google Scholar
41	Lee J and Kang H: Hypoxia promotes vascular smooth muscle cell proliferation through microRNA-mediated suppression of cyclin-dependent kinase inhibitors. Cells. 8:8022019. View Article : Google Scholar :
42	Kwon H, Lee JJ, Lee JH, Cho WK, Gu MJ, Lee KJ and Ma JY: Cinnamon and its components suppress vascular smooth muscle cell proliferation by up-regulating cyclin-dependent kinase inhibitors. Am J Chin Med. 43:621–636. 2015. View Article : Google Scholar : PubMed/NCBI
43	Yu JY, Lee JJ, Jung JK, Kim TJ, Yoo HS, Yun YP and Lee JC: JY0691, a newly synthesized obovatol derivative, inhibits cell cycle progression of rat aortic smooth muscle cells through up-regulation of p21(cip1). Eur J Pharmacol. 624:23–30. 2009. View Article : Google Scholar : PubMed/NCBI
44	Poon RY, Jiang W, Toyoshima H and Hunter T: Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J Biol Chem. 271:13283–13291. 1996. View Article : Google Scholar : PubMed/NCBI
45	Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, et al: Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 178:81–88. 2008. View Article : Google Scholar : PubMed/NCBI
46	Jandl K, Thekkekara Puthenparampil H, Marsh LM, Hoffmann J, Wilhelm J, Veith C, Sinn K, Klepetko W, Olschewski H, Olschewski A, et al: Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: The role of PAXIP1-AS1. J Pathol. 247:357–370. 2019. View Article : Google Scholar :